Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

149
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
149
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

551
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
551
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

231
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
231

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effects of Incretin Mimetic Therapies on Muscle and Bone Health in Older Adults: A Narrative Review.

Obesity (Silver Spring, Md.)·2026
Same author

Association of Testosterone With Lean Soft Tissue and Handgrip Strength Across Middle-Aged Men.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Allostatic Load in Endometrial Cancer Disparities.

medRxiv : the preprint server for health sciences·2026
Same author

Central auditory tests reveal deficits in HIV treatment.

Frontiers in public health·2026
Same author

Contribution of Obesity to Polypharmacy in U.S. Older Adults.

Journal of general internal medicine·2026
Same author

Current application and future directions for the sarcopenic obesity Global Leadership Initiative (SOGLI) diagnostic algorithm.

Clinical nutrition (Edinburgh, Scotland)·2026

Related Experiment Video

Updated: Aug 2, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Domain-aware Intermediate Pretraining for Dementia Detection with Limited Data.

Youxiang Zhu1, Xiaohui Liang1, John A Batsis2

  • 1University of Massachusetts Boston.

Interspeech
|April 17, 2023
PubMed
Summary

Domain-aware intermediate pretraining enhances dementia detection from speech by using similar datasets. This approach helps overcome data limitations and reduce overfitting in machine learning models for early diagnosis.

Keywords:
Dementiaintermediate pretrainingperplexity

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K

Related Experiment Videos

Last Updated: Aug 2, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K

Area of Science:

  • Computational linguistics
  • Artificial intelligence in healthcare
  • Neuroscience

Background:

  • Dementia detection via human speech shows promise but is hindered by limited data.
  • General pretrained models (e.g., BERT) can improve dementia detection but are prone to overfitting when fine-tuned on small dementia datasets.

Purpose of the Study:

  • To propose a domain-aware intermediate pretraining method to improve dementia detection from speech.
  • To address the overfitting challenge in fine-tuning large models with limited dementia-specific data.

Main Methods:

  • Utilized pseudo-perplexity to select domain-similar datasets for intermediate pretraining.
  • Developed dataset-level and sample-level domain-aware intermediate pretraining techniques.
  • Introduced IU-pseudo-perplexity, incorporating information units (IU) to reduce calculation complexity.

Main Results:

  • Confirmed the effectiveness of perplexity in predicting model accuracy across 9 GLUE benchmark datasets.
  • Demonstrated that domain-aware intermediate pretraining significantly improves dementia detection accuracy in most cases.
  • Observed small differences in text-based perplexity between Alzheimer's Disease (AD) patients and Healthy Controls (HC).

Conclusions:

  • Domain-aware intermediate pretraining is an effective strategy for enhancing dementia detection from speech.
  • Incorporating acoustic features alongside text-based perplexity may further improve pretraining effectiveness.
  • The proposed method offers a viable solution to the data scarcity problem in clinical AI applications.